Predictions for Health Tech Innovators: 2023

By Josh Gray

What lies ahead for innovative health technologies companies in 2023? Heading into 2022, we predicted a tough year for startups. If anything, we understated the situation: the funding environment is dramatically tougher, with little prospect of relief in the near future. We also anticipated that “early advocates using AI in controlled settings will lead the way to broader adoption at the point of care.”  In actuality, the diffusion of AI in clinical practice is proceeding more slowly than we anticipated.  Controversies surrounding the validation and performance limitations of the Epic Sepsis predictor have continued to have a negative impact on some user perceptions of the pace of AI adoption at the bedside. My colleagues and I at Health Data Analytics Institute support rigorous assessment of AI products as evidenced by our recent publication of our validation study in Anesthesiology

Prediction #1: Another brutal year ahead for innovative health care startups

The venture-fueled expansion of health care startups came to a screeching halt in 2022. Between 2015 and 2019, health tech startups raised an average of $6.4 billion annually in venture funding (Rock Health citation) at an average deal size of $17.1 million. By 2021, investment nearly quintupled (to $29.2 billion!) while the deal size more than doubled, to $39.7 million. With enthusiasm for digital innovation at a fever pitch and investors fearful of missing out, entrepreneurs enjoyed easy access to funding and generous valuations on business propositions that were more grounded in vision than results. 

The investment environment in the second half of 2022 could hardly be more different. Consider the fate of three companies hailed for innovation in 2020 and 2021. Bright Health is an insurtech company that IPO’ed in 2021; Oscar Health promised to use analytics to personalize care for individual beneficiaries; and American Well rode the COVID-driven telemedicine wave. All three of these unicorns failed to sustain their value propositions and have lost 90% or more of their value, losing investors billions of dollars. Reflecting the loss of investor confidence, there were 20 digital health IPOs in 2021 and none in the first half of 2022.

Not being able to count on public market exits, venture capitalists have cut way back on their investments, making it difficult for startups to raise capital that seemed a sure bet just a year ago. Many startups will need to stretch their cash reserves long enough to reach breakeven or at least until VCs are once again ready to write checks, which could be a long wait. Many health startups (Ro, Noom, Cerebral, and Cedar) have made significant layoffs and we can expect many others to follow suit. The scramble for revenue will be made still more challenging given the many health systems dealing with steep financial losses due to weak volumes and labor shortfalls, which are driving up labor costs and, in some cases, depressing volumes of elective procedures.  During these contractive periods, it is harder to sell vision to investors; to the extent that investments get made, they will likely be with lean startups able to communicate clear compelling value propositions along with compelling business and clinical results.  Others will have trouble surviving. 

Prediction #2:  More PCPs will pursue partnerships, not employment

The Center for Medicare and Medicaid Services (CMS) plans to migrate virtually all Medicare beneficiaries to value based care arrangements by 2030, and many commercial and Medicaid plans are following suit. Primary care physicians will play a pivotal role in this transition. Of all clinicians, PCPs are in the best position to manage chronic disease and minimize the number of high-cost acute events:  the success of value-based care arrangements is highly dependent on the engagement of dedicated, high quality primary care providers.

Yet despite their central importance to the health care system, PCPs experience high rates of burnout and professional dissatisfaction. Those who attempt to remain independent find themselves struggling to survive given the high costs and administrative complexities of managing a modern practice.  Many others have accepted employment in large health systems.  Many of these employee physicians feel alienated because they have little control over their day-to-day practice and working conditions.

Consequently, we expect more primary care physicians to partner with firms that will allow them to practice independently while enabling them to profit from value-based care contracts.  Companies like Agilon, Aledade, Caravan, and others do not employ PCPs but supply them with analytics, contracting support, and in some instances case management, equipping them to make the transition to value-based care manageable and lucrative. Of course, only some of these partnerships will be successful. But given the difficulties of remaining completely independent and the professional frustrations of employment, we think more PCPs will choose the option of partnering with companies that help them provide value-based care profitably, while remaining independent. 

Prediction #3:  Consumer-oriented corporations will increase market share by providing patients with better access

Have you, your family, or friends had to wait three months or (much) more for a primary care appointment? Have they struggled to find a new PCP when they move or when their old physicians retire?  Mine have. Ambulatory care volumes have risen closer to pre-COVID levels, but during the pandemic, many providers cut back their clinical hours or left the profession altogether. As a result, patients are finding it harder to access care in a way that works for them.

Large, national brands are stepping to fill this void. Walgreens spent $5.2 billion to acquire Village MD and $9 billion to acquire Summit Health, a provider group with primary, specialty, and urgent care services. Walgreens currently has about 80 primary care locations and plans to have 1,000 by 2027. CVS, which owns Aetna, already has 1,000 Minute Clinics and more than 100 Health Hubs designed to provide primary care and to help patients manage their chronic disease.  Walmart is a key health care provider in rural markets, providing full service primary care adjacent to its retail super centers. 

These large companies are well positioned to provide patients with much faster access to care than they receive from conventional physician groups. They are deeply experienced in understanding and responding to consumer needs. This, combined with their growing expertise in digital medicine, allows them to provide patients with convenient, relatively low-cost care. Unless providers can ensure patients have fast access and a positive service experience, they should be prepared to lose patients to consumer oriented for-profit companies.  

Your privacy matters

We believe that an individual’s meaningful control over their own data is as valuable as the data itself. That’s why we are committed to protecting privacy at every turn.
We always:
  • Provide transparency about the information we collect and why we collect it
  • Comply with all applicable privacy rules and regulations
  • Delete personal data from our servers if an individual opts out
We never:
  • Sell data to third parties
  • Share data with third parties besides the primary, explicitly authorized institution
  • Collect data besides what is disclosed
  • Keep personal data for individuals who have opted out

We speak legalese only when we have to, but we do our best to keep it human. Provided below are the full versions of our Privacy Policy and Terms of Service. If you have any questions, don’t hesitate to contact us for clarification.

George Pace

VP Business Development, Payer Markets

George has over two decades of consulting, business development and client success experience in health care, working with both providers and payers to address their most pressing challenges. The bulk of his healthcare career was with The Advisory Board, Optum, Premier and Verisk Health, with a focus on risk mitigation, value-based care and population health management. He is deeply passionate about helping healthcare organizations do their best for their patients and beneficiaries. 

When he’s not working, you will find him playing guitar, riding his bike or spending time with family, friends, and his dog Luna.  

Summer Kramer
VP Clinical Programs

Summer is a clinical pharmacist with over 15 years of experience in the healthcare industry, including hospitals, payors, and start-ups. Summer has focused her career on clinical program development and healthcare analytics with a constant drive to improve patient outcomes.

Residing in the pacific northwest, Summer enjoys hiking, camping, sailing, and traveling. She received her PharmD from the University of New Mexico, College of Pharmacy.  

Karan (Kay) Mansukhani
VP Business Development

Kay has a decade of experience in population health analytics.  Starting his career in Maryland’s state-designated HIE – CRISP,  he was entrusted to set up the infrastructure and data elements needed by health system to achieve CMMIs Triple Aim. Kay is a trained epidemiologist who has a passion for preventive medicine, psychology, and anthropology. Kay enjoys spending lazy days with his wife Sonal, and son Avtar on the beach.  Kay also enjoys listening to podcasts, playing the guitar and badminton. He received his joint MPH MBA from Johns Hopkins University.

Kevin Sampson
VP Finance

Kevin is a CPA with 25 years of executive and managerial experience in accounting, corporate finance, and operations in a variety of industries including medical device, biotechnology, and pharmaceuticals.

By listening and connecting with people, Kevin understands that accurate timely information is vital for everyone in the healthcare system. He received a BS in Accounting and an MBA in Finance and Entrepreneurial Studies from Babson College.

Paul Manberg
VP Clinical and Regulatory Affairs

Paul is an innovative, pragmatic leader with over 40 years’ experience in the medical device and pharmaceutical industries. He has directed clinical trial programs and regulatory activities supporting the successful market introduction of numerous impactful products. He spends his leisure time on the Outer Banks of North Carolina, body surfing and fishing. He received a PhD in pharmacology from The University of North Carolina School of Medicine.

Scott Greenwald
Chief Scientist

With over 25 years’ experience in healthcare research and innovation, Scott is an unprecedented leader in his field, focusing on improved care for everyone. He is an author of over 10 US Patents and over 100 peer-reviewed abstracts and manuscripts. While he’s not immersed in research, you’ll find him playing a mean round of mini golf. He received a PhD in Medical Engineering from the Harvard-MIT Division of Health Sciences and Technology (HST).

Josh Gray
VP Analytic Services
Josh has 30 years’ experience in healthcare, including The Advisory Board Company, athenahealth, and Boston Consulting Group. Across his career, he has used a wide range of conventional and unconventional data sources to understand and teach the keys to top performance among the nation’s most innovative health systems and physician groups. Josh enjoys music, hiking, traveling, and watching his daughter take part in synchronized skating competitions. He received an MBA from The Wharton School at the University of Pennsylvania and an undergraduate degree from Brown University.
Carola Endicott
VP Customer Engagement, Marketing

Carola has 30 years’ experience in healthcare, including HMOs, hospitals, and start-ups. Her knowledge and optimistic outlook in operations and leadership, and her passion for making healthcare workers’ lives easier is what drives her devotion to customer engagement. She received an EdM from Harvard University Graduate School of Education.

David Clain
Chief Product Officer
David has vast experience with healthcare customers from his time at The Advisory Board Company and athenahealth. His expertise and passion for statistics, strategy, and innovative analytic insights is unrivaled, as is his devotion to the Duke Blue Devils. Looking for that “aha moment” of positive change is what drives him. He received a BA from Duke University.
Margie Ahearn

Margie has 25 years of experience in HR leadership. An avid boater, Margie has received numerous awards for excellence in HR and is always looking for challenges to grow professionally and personally. She graduated with an MBA from Southern New Hampshire University.

Nassib Chamoun
Founder and CEO and cheerleader-in-chief

Nassib is a data scientist, lover of logistical regression and serial entrepreneur. Outside of work he enjoys hosting and honing his cooking skills – specializing in Middle Eastern and outdoor feasts. He received an MS from Boston University.

Phil Devlin

Phil has 30 years of experience in executive leadership. Along his journey he’s made effective and profound change in science. Little known facts about him — he loves traveling with his family, he was in the MD Engineering program at Harvard Medical School and owns 15 patents. He received an MS from Northeastern University.

What guides our culture


We are driven to make a profound impact on US healthcare


We operate in the best interests of patients and those who serve them


We understand and protect patient privacy and health information security


We use data science to enhance, but never replace clinical expertise and judgment


We are committed to continuous learning and improvement


We bring rigor, discipline, and reliability to our work


We start with kindness, assuming good intent in others


We are committed to building a diverse, inclusive team where all employees feel welcomed and appreciated


We are committed to the well-being of our employees and their families

Phil Devlin

Phil has 30 years of experience in executive leadership. Along his journey he’s made effective and profound change in science. Little known facts about him — he loves traveling with his family, he was in the MD Engineering program at Harvard Medical School and owns 15 patents. He received an MS from Northeastern University.